Moderna Files Lawsuit For Patent Infringement Against Pfizer/BioNTech

Objectivity 4.0 | Credibility 4.6 | Relevance 4.8

Moderna filed a lawsuit against Pfizer and BioNTech for patent infringement for allegedly copying the technology used in the COVID-19 vaccine without permission.  In 2021, Moderna’s revenue from their vaccine was $10.4 billion compared to revenue from Pfizer’s vaccine at $22 billion.  When new pharmacological technology is emmerging, patent litigation is not uncommon.  Currently, Moderna is in an ongoing dispute over the rights to mRNA technology with the U.S. National Institutes of Health (NIH).